{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:42:35Z","timestamp":1790869355375,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.lungcan.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T14:46:19Z","timestamp":1343832379000},"page":"23-29","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Bruno","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubiratan","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2012.07.005_bib0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1470-2045(04)01492-5","article-title":"Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development","volume":"5","author":"Fennell","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/carcin\/bgr127","article-title":"Pleural mesothelioma side populations have a precursor phenotype","volume":"32","author":"Frei","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/146532402761624638","article-title":"Multipotential stem cells and \u2018side population\u2019 cells","volume":"4","author":"Goodell","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells","volume":"6","author":"Szakacs","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0030","doi-asserted-by":"crossref","first-page":"39068","DOI":"10.1074\/jbc.M306362200","article-title":"Akt signaling regulates side population cell phenotype via Bcrp1 translocation","volume":"278","author":"Mogi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/dmd.104.003228","article-title":"Regulation of the cell surface expression of human BCRP\/ABCG2 by the phosphorylation state of Akt in polarized cells","volume":"33","author":"Takada","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0040","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/carcin\/bgn223","article-title":"Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0045","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0055","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1158\/1535-7163.MCT-09-0160","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas","volume":"8","author":"Liu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0060","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"Chiarini","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0065","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Schmitter","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0075","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1074\/jbc.M411338200","article-title":"Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface","volume":"280","author":"Ozvegy-Laczka","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0080","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter ABCG2 (Mxr\/BCrp\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0085","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1124\/dmd.111.039370","article-title":"pH-Dependent transport of pemetrexed by breast cancer resistance protein","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0090","first-page":"1677","article-title":"Inhibition of activated phosphatidylinositol 3-kinase\/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest","volume":"24","author":"Mikami","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: a perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0100","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1158\/0008-5472.CAN-07-2154","article-title":"A dual phosphoinositide-3-kinase alpha\/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma","volume":"67","author":"Fan","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-010-1232-1","article-title":"The PI3 kinase\/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","volume":"129","author":"Brunner-Kubath","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0110","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/sj.onc.1208744","article-title":"Human and mouse mesotheliomas exhibit elevated AKT\/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","author":"Cedres","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1272874","article-title":"Update on malignant pleural mesothelioma","volume":"32","author":"Campbell","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"van Meerbeeck","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejcts.2007.09.045","article-title":"PTEN expression is a strong predictor of survival in mesothelioma patients","volume":"33","author":"Opitz","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","article-title":"PTEN level in tumor suppression: how much is too little?","volume":"71","author":"Carracedo","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2010.12.005","article-title":"Non-genomic loss of PTEN function in cancer: not in my genes","volume":"32","author":"Leslie","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng1975","article-title":"High-throughput oncogene mutation profiling in human cancer","volume":"39","author":"Thomas","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0155","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1158\/0008-5472.CAN-04-1898","article-title":"Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes","volume":"64","author":"Hoang","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0160","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1158\/0008-5472.CAN-09-4360","article-title":"Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells","volume":"70","author":"Xia","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0165","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/1078-0432.CCR-0937-3","article-title":"Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer","volume":"10","author":"Yoh","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/JTO.0b013e318215a07d","article-title":"Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy","volume":"6","author":"Brevet","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma","volume":"13","author":"Ou","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.lungcan.2012.07.005_bib0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1827.2011.02666.x","article-title":"Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation","volume":"61","author":"Sekido","year":"2011","journal-title":"Pathol Int"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212004308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500212004308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T19:29:07Z","timestamp":1542828547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500212004308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0169500212004308"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2012.07.005","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}